214 related articles for article (PubMed ID: 1522168)
1. Therapeutic approaches to recurrent peptic ulcer disease.
Cave DR
Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
[No Abstract] [Full Text] [Related]
2. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
Fedotin MS
Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
[TBL] [Abstract][Full Text] [Related]
3. Peptic ulcer treatment today--is there a role for maintenance therapy?
Breslin NP; O'Morain C
Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
[No Abstract] [Full Text] [Related]
4. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Park KN; Hahm JS; Kim HJ
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
Peura DA; Graham DY
Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
[No Abstract] [Full Text] [Related]
6. Helicobacter pylori therapy: effect on peptic ulcer disease.
Axon AT
J Gastroenterol Hepatol; 1991; 6(2):131-7. PubMed ID: 1912418
[No Abstract] [Full Text] [Related]
7. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
López-Brea M; Alarcón T
Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
[No Abstract] [Full Text] [Related]
8. Management of Helicobacter pylori-positive peptic ulcer disease.
Malfertheiner P
Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
[No Abstract] [Full Text] [Related]
9. [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori].
Grigor'ev PIa; Isakov VA; Iakovenko EP; Soluianova IP
Ter Arkh; 1992; 64(8):101-4. PubMed ID: 1440381
[No Abstract] [Full Text] [Related]
10. New concepts concerning management of Helicobacter pylori infection: 2 years after the Maastricht Consensus Report.
Gasbarrini G; Malfertheiner P; Deltenre M; Mégraud F; O'Morain C; Pajares-García J; Quina M; Bianchi Porro G; Gasbarrini A; Franceschi F; Armuzzi A; Cammarota G; Anti M; Pretolani S
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S244-7. PubMed ID: 10077746
[No Abstract] [Full Text] [Related]
11. Treating peptic ulcer: an ongoing challenge.
Cohen MH
J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
[No Abstract] [Full Text] [Related]
12. The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Avidan B; Melzer E; Keller N; Bar-Meir S
Isr Med Assoc J; 2001 Mar; 3(3):163-5. PubMed ID: 11303370
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori: can it be a contributing factor in peptic ulcer in childhood?].
Tovar-Calderón S; Casaubón-Garcín P; Ramírez-Mayans J; Cervantes R
Bol Med Hosp Infant Mex; 1991 Oct; 48(10):743-8. PubMed ID: 1764199
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies for Helicobacter pylori infection.
Damianos AJ; McGarrity TJ
Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
[TBL] [Abstract][Full Text] [Related]
15. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
16. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori infection.
Suerbaum S; Michetti P
N Engl J Med; 2002 Oct; 347(15):1175-86. PubMed ID: 12374879
[No Abstract] [Full Text] [Related]
18. Peptic ulcer recurrence and Helicobacter pylori: evidence from Japan.
Tsuji S; Kawano S
J Gastroenterol; 2003; 38(4):410-1. PubMed ID: 12743786
[No Abstract] [Full Text] [Related]
19. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
[No Abstract] [Full Text] [Related]
20. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
[Next] [New Search]
